Several studies have reported that depression and anxiety are very common in atrial fibrillation due to impaired quality of life. Dabigatran is an anti-aggregation agent used for the treatment of atrial fibrillation. In terms of drug interactions during treatment with dabigatran, patients suffering from minor depression are reported to be a population at risk. This report is about a 68-year-old man whose depressive symptoms were aggravated after taking dabigatran for atrial fibrillation. The case is discussed in terms of his aggravated depressive symptoms and the interaction between his prescription medications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/psyg.12099 | DOI Listing |
Publication Analysis
Top Keywords
depressive symptoms
12
atrial fibrillation
12
symptoms associated
4
dabigatran
4
associated dabigatran
4
dabigatran case
4
case report
4
report studies
4
studies reported
4
reported depression
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!